# OnCo record coregen (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/coregen/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "coregen" ;
  schema:name "CoRegen"@en ;
  schema:description "CoRegen develops a cell therapy made from a patient's own regulatory T cells, immune cells that normally calm the immune system, edited so that they help it attack cancer instead. Its first product is about to enter an early trial in breast and prostate cancer."@en ;
  schema:url <https://onco.cc/companies/coregen/>, <https://www.coregen.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.coregen.com/>, <https://www.coregen.com/news> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/tnbc-metastatic/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:trials <https://onco.cc/trials/nct07730125/> .